Key Market Indicators
The country was number 16 in 2021, Germany came ahead with $39,313,000. Canada, United Kingdom and France respectively ranked numbers 2, 3 and 4 in this ranking. Sales of diabetes medicines in Chile are projected to reach $301 million by 2026, up from $243 million in 2021. This amounts to an average annual growth rate of 3.6%, which is slightly higher than the 11.2% growth rate seen since 2005. Sweden was the leading market in 2021 with $243 million, followed by Canada, Spain, and Italy. Exports of insulin from Chile are expected to rise to $337,000 by 2026, up from $254,000 in 2021. This represents a compound annual growth rate of 5%, higher than the 15.1% growth rate since 2008. Morocco was the top supplier in 2021 with $254,000, followed by France, Italy, and China. Imports of insulin to Chile are forecast to reach $49 million by 2026, up from $39 million in 2021. This is an average annual growth rate of 3.5%, which is lower than the 10.8% growth rate seen since 1995. Germany was the leading market in 2021 with $39 million, followed by Canada, the United Kingdom, and France.
